Exchange: NASDAQ·Updated 07:51 PM EDT
CAPR logo

CAPR Capricor Therapeutics Inc

$9.40
$0.12
(1.29%)
Today
Closed $9.40
$0.03
(0.32%)
After Hours
Reported EarningsAug 13
Mkt Cap$546.51M
Vol2.56M

About CAPR

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
31

Bearish Sentiment

How do you feel about CAPR?

Advertisement|Remove ads.